The weekly interval matches methionine's elimination half-life of 2.53 days, allowing sustained lipotropic activity without accumulation
Programs can range from a few months to over a year. What makes medical weight loss different from commercial weight loss programs
doi: 10.1016/j.clinre.2016.11.009 Summary Keywords glucagon-like peptide-1 receptor agonists, metabolic disease, metabolic dysfunction-associated steatotic liver disease, public health, umbrella review Citation Wu H, Zhang Z-H, Ye T, Chen J-N, Tung T-H and Zhu J-S (2026) Efficacy and safety of GLP-1 receptor agonists in patients with metabolic-associated fatty liver diseases: an umbrella review
This lactate buildup can cause muscle fatigue, soreness, etc., hence decreasing performance
A patient may be a candidate for GLP-1 injections if they are struggling with weight loss, appetite control, overeating, cravings, obesity, or weight-related health concerns
Nayan Patel: No, it should not
